Richard Jeffs is 10% Owner at Cell MedX Corp. (CMXC). They have made 69 open-market trades across 4 companies since 2007, most recently 2025-02-24.
CIK 0001182941
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
65 open-market purchases totalling $2.1M since 2007, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STME | BUY | 2025-02-21 | 2025-02-25 | $0.17 | $3K | N/A | N/A | N/A |
| CMXC | BUY | 2023-12-29 | 2024-01-09 | $0.01 | $287K | N/A | N/A | N/A |
| RMESF | BUY | 2022-06-03 | 2022-06-06 | $0.12 | $10K | N/A | N/A | N/A |
| RMES | SELL | 2021-04-27 | 2021-04-27 | $0.41 | $2K | N/A | N/A | N/A |
| RMES | SELL | 2021-04-26 | 2021-04-28 | $0.41 | $10K | N/A | N/A | N/A |
| RMES | SELL | 2021-04-16 | 2021-04-20 | $0.25 | $8K | N/A | N/A | N/A |
| RMES | BUY | 2021-04-05 | 2021-04-06 | $0.15 | $5K | N/A | N/A | N/A |
| RMES | BUY | 2021-03-01 | 2021-03-02 | $0.13 | $135 | N/A | N/A | N/A |
| RMES | BUY | 2020-12-23 | 2020-12-30 | $0.10 | $260 | N/A | N/A | N/A |
| CMXC | SELL | 2020-04-27 | 2020-04-28 | $0.60 | $10K | N/A | N/A | N/A |
| CMXC | BUY | 2020-04-21 | 2020-04-28 | $0.15 | $152K | N/A | N/A | N/A |
| CMXC | BUY | 2020-04-15 | 2020-04-17 | $0.33 | $3K | N/A | N/A | N/A |
| CMXC | BUY | 2020-04-13 | 2020-04-16 | $0.30 | $11K | N/A | N/A | N/A |
| CMXC | BUY | 2020-04-08 | 2020-04-13 | $0.30 | $11K | N/A | N/A | N/A |
| CMXC | BUY | 2020-04-03 | 2020-04-07 | $0.21 | $6K | N/A | N/A | N/A |
| CMXC | BUY | 2020-02-06 | 2020-02-10 | $0.30 | $3K | N/A | N/A | N/A |
| RMES | BUY | 2020-01-31 | 2020-02-04 | $0.05 | $125 | N/A | N/A | N/A |
| CMXC | BUY | 2020-01-30 | 2020-01-31 | $0.25 | $3K | N/A | N/A | N/A |
| RMES | BUY | 2020-01-29 | 2020-01-31 | $0.05 | $3K | N/A | N/A | N/A |
| RMES | BUY | 2020-01-17 | 2020-01-21 | $0.06 | $3K | N/A | N/A | N/A |
| RMES | BUY | 2020-01-10 | 2020-01-13 | $0.07 | $5K | N/A | N/A | N/A |
| RMES | BUY | 2020-01-06 | 2020-01-08 | $0.04 | $14 | N/A | N/A | N/A |
| RMES | BUY | 2020-01-02 | 2020-01-03 | $0.05 | $3K | N/A | N/A | N/A |
| RMES | BUY | 2019-12-26 | 2019-12-30 | $0.04 | $2K | N/A | N/A | N/A |
| RMES | BUY | 2019-12-23 | 2019-12-26 | $0.04 | $1K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.